• Facebook
  • Twitter
x

RealTime Images

  • Portfolio
  • About
  • Contact
  • Video
  • Blog
  • Archive
Show Navigation
Cart Lightbox Client Area

Search Results

Refine Search
Match all words
Match any word
Prints
Personal Use
Royalty-Free
Rights-Managed
(leave unchecked to
search all images)
Next
{ 1114 images found }
twitterlinkedinfacebook

Loading ()...

  • MICHAEL JOSEPH JACKSON (Aug. 29, 1958 - Jun. 25, 2009) recording artist superstar, entertainer, businessman died at age 50. Known as the 'King of Pop', Jackson rocketed to fame at age 11, as a member of The Jackson 5 in 1968. He went solo in 1971, and his 1982 album 'Thriller' remains the world's best-selling album of all time. PICTURED: MICHAEL JACKSON, in jacket and glove costume from the Jacksons' 1984 'Victory' Tour. (Credit © Harrison Funk/ZUMApress.com)
    19830101_jes_f73_896.jpg
  • EXCLUSIVE: *NO WEB UNTIL 1PM BST 3RD SEPT* David Beckham takes his Children to the Boxing Gym. David took Harper, Romeo and Cruz to his West London Boxing Gym for a work out. All the Children left clutching Boxing Glove's and Harper carried a Water Blaster. 01 Sep 2017 Pictured: David Beckham, Romeo Beckham, Cruz Beckham, Harper Beckham. Photo credit: MEGA TheMegaAgency.com +1 888 505 6342
    RTIMEGA75606_004.jpg
  • EXCLUSIVE: *NO WEB UNTIL 1PM BST 3RD SEPT* David Beckham takes his Children to the Boxing Gym. David took Harper, Romeo and Cruz to his West London Boxing Gym for a work out. All the Children left clutching Boxing Glove's and Harper carried a Water Blaster. 01 Sep 2017 Pictured: David Beckham, Romeo Beckham, Cruz Beckham, Harper Beckham. Photo credit: MEGA TheMegaAgency.com +1 888 505 6342
    MEGA75606_010.jpg
  • February 15, 2018 - Young man wearing work gloves standing next to a stack of wooden planks in a warehouse, holding plank, looking up. (Credit Image: © Mint Images via ZUMA Wire)
    20180215_zaa_m137_026.jpg
  • Gloves, bat and helmet on the pitch
    PA-6058577.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_084.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_083.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_082.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_080.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_079.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_078.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_074.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_073.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_071.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_070.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_069.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_067.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_065.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_063.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_053.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_051.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_038.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_036.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_035.jpg
  • Manchester United's Romelu Lukaku during the FA Cup, Fourth Round match at the Emirates Stadium, London.
    40835728.jpg
  • Arsenal's Pierre-Emerick Aubameyang during the FA Cup, Fourth Round match at the Emirates Stadium, London.
    40835724.jpg
  • Manchester United goalkeeper Sergio Romero during the FA Cup, Fourth Round match at the Emirates Stadium, London.
    40835721.jpg
  • Manchester United's Anthony Martial in action during the UEFA Champions League, Group H match at Old Trafford, Manchester.
    39916101.jpg
  • Sheffield Wednesday goalkeeper Cameron Dawson instructs his wall during the game
    39213666.jpg
  • Everton goalkeeper Jordan Pickford warming up before the game
    38564596.jpg
  • Sussex Sharks' Michael Burgess bats during the Vitality T20 Blast Final on Finals Day at Edgbaston, Birmingham.
    38547969.jpg
  • Sussex Sharks' Michael Burgess bats during the Vitality T20 Blast Final on Finals Day at Edgbaston, Birmingham.
    38547966.jpg
  • Sussex Sharks' Laurie Evans is bowled out by Worcestershire Rapids' Ed Barnard during the Vitality T20 Blast Final on Finals Day at Edgbaston, Birmingham.
    38547820.jpg
  • Sussex Sharks' David Wiese reacts after being bowled out by Worcestershire Rapids' Moeen Ali during the Vitality T20 Blast Final on Finals Day at Edgbaston, Birmingham.
    38547816.jpg
  • Sussex Sharks' David Wiese bats during the Vitality T20 Blast Final on Finals Day at Edgbaston, Birmingham.
    38547660.jpg
  • Sussex Sharks' David Wiese reacts after being bowled out by Worcestershire Rapids' Moeen Ali during the Vitality T20 Blast Final on Finals Day at Edgbaston, Birmingham.
    38547642.jpg
  • Sussex Sharks' David Wiese reacts after being bowled out by Worcestershire Rapids' Moeen Ali during the Vitality T20 Blast Final on Finals Day at Edgbaston, Birmingham.
    38547639.jpg
  • England's Jack Butland during the training session at St Georges' Park, Burton.
    38454208.jpg
  • Burnley goalkeeper Joe Hart at half-time
    37994811.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_081.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_077.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_076.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_075.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_072.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_068.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_066.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_064.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_062.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_056.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_055.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_054.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_052.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_050.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_049.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_048.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_045.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_044.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_043.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_041.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_040.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_039.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_037.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_034.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_033.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_031.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_001.jpg
  • Manchester United's Romelu Lukaku during the FA Cup, Fourth Round match at the Emirates Stadium, London.
    40835729.jpg
  • Manchester United's Romelu Lukaku during the FA Cup, Fourth Round match at the Emirates Stadium, London.
    40835727.jpg
  • Arsenal's Pierre-Emerick Aubameyang during the FA Cup, Fourth Round match at the Emirates Stadium, London.
    40835723.jpg
  • Arsenal's Pierre-Emerick Aubameyang during the FA Cup, Fourth Round match at the Emirates Stadium, London.
    40835722.jpg
  • Manchester United goalkeeper Sergio Romero during the FA Cup, Fourth Round match at the Emirates Stadium, London.
    40835716.jpg
  • England goalkeeper Jordan Pickford during the training session at Ciudad Deportiva Luis del Sol, Seville.
    39120000.jpg
  • Worcestershire Rapids' Moeen Ali hits a boundary during the Vitality T20 Blast Final on Finals Day at Edgbaston, Birmingham.
    38548604.jpg
  • Worcestershire Rapids' Moeen Ali bats during the Vitality T20 Blast Final on Finals Day at Edgbaston, Birmingham.
    38548598.jpg
  • Worcestershire Rapids' Moeen Ali hits a boundary during the Vitality T20 Blast Final on Finals Day at Edgbaston, Birmingham.
    38548592.jpg
  • Worcestershire Rapids' Joe Clarke bats during the Vitality T20 Blast Final on Finals Day at Edgbaston, Birmingham.
    38548586.jpg
  • Sussex Sharks' Jofra Archer bats during the Vitality T20 Blast Final on Finals Day at Edgbaston, Birmingham.
    38547972.jpg
  • Sussex Sharks' Jofra Archer bats during the Vitality T20 Blast Final on Finals Day at Edgbaston, Birmingham.
    38547963.jpg
  • Sussex Sharks' Laurie Evans is bowled out by Worcestershire Rapids' Ed Barnard during the Vitality T20 Blast Final on Finals Day at Edgbaston, Birmingham.
    38547818.jpg
  • Burnley goalkeeper Joe Hart blows a kiss to the fans at half-time
    37994812.jpg
  • England goalkeeper Jordan Pickford saves a penalty from Colombia's Carlos Bacca during the FIFA World Cup 2018, round of 16 match at the Spartak Stadium, Moscow.
    37367872.jpg
  • England goalkeeper Jordan Pickford saves a penalty from Colombia's Carlos Bacca during the FIFA World Cup 2018, round of 16 match at the Spartak Stadium, Moscow.
    37367824.jpg
  • Rita Ora attending the Metropolitan Museum of Art Costume Institute Benefit Gala 2018 in New York, USA.
    RTI36370347.jpg
  • Street style, Didem Celebi arriving at Ludovic de Saint Sernin Spring Summer 2022 show, held at Institut du Monde Arabe, Paris, France, on Ocotber 3rd, 2021. Photo by Marie-Paola Bertrand-Hillion/ABACAPRESS.COM
    783663_039.jpg
  • Street style, Didem Celebi arriving at Ludovic de Saint Sernin Spring Summer 2022 show, held at Institut du Monde Arabe, Paris, France, on Ocotber 3rd, 2021. Photo by Marie-Paola Bertrand-Hillion/ABACAPRESS.COM
    783663_038.jpg
  • Street style, Didem Celebi arriving at Ludovic de Saint Sernin Spring Summer 2022 show, held at Institut du Monde Arabe, Paris, France, on Ocotber 3rd, 2021. Photo by Marie-Paola Bertrand-Hillion/ABACAPRESS.COM
    783663_037.jpg
  • Street style, Didem Celebi arriving at Ludovic de Saint Sernin Spring Summer 2022 show, held at Institut du Monde Arabe, Paris, France, on Ocotber 3rd, 2021. Photo by Marie-Paola Bertrand-Hillion/ABACAPRESS.COM
    783663_036.jpg
  • Edith Bowman attending the 73rd British Academy Film Awards held at the Royal Albert Hall, London.
    50042667.jpg
  • German designer Karl Lagerfeld launches the Net-a-Porter in Paris, France on January 25, 2012. Photo by Mousse/ABACAPRESS.COM
    305875_022.jpg
  • German designer Karl Lagerfeld launches the Net-a-Porter in Paris, France on January 25, 2012. Photo by Mousse/ABACAPRESS.COM
    305875_021.jpg
  • German designer Karl Lagerfeld launches the Net-a-Porter in Paris, France on January 25, 2012. Photo by Mousse/ABACAPRESS.COM
    305875_019.jpg
  • German designer Karl Lagerfeld launches the Net-a-Porter in Paris, France on January 25, 2012. Photo by Mousse/ABACAPRESS.COM
    305875_010.jpg
  • German designer Karl Lagerfeld makes an appareance for Chanel Spring-Summer 2012 Ready-To-Wear collection show held at La Grand Palais, in Paris, France, on October 4, 2011. Photo by Alain Gil-Gonzalez/ABACAPRESS.COM
    292377_085.jpg
  • Karl Lagerfeld makes an appearance after Chanel Spring-Summer 2012 Ready-To-Wear collection show held at La Grand Palais, in Paris, France, on October 4, 2011. Photo by Thierry Orban/ABACAPRESS.COM
    292371_012.jpg
  • German fashion designer Karl Lagerfeld attends a ceremony where he received the Commander's Cross of the Legion of Honour (Croix de Commander de la Legion d'Honneur) at the Elysee Palace in Paris, France on June 3, 2010. Photo by Jacky Naegelen/Pool/ABACAPRESS.COM
    233205_003.jpg
  • Karl Lagerfeld poses in Paris, France, in March 2006. Photo by VIM/ABACAPRESS.COM
    108442_18.jpg
  • Manchester City Super fan "Pete The Badge" in the stands prior to the beginning of the match
    40994591.jpg
  • goalkeeper Loris Sven Karius of Besiktas JK during the UEFA Europa League group I match between between Besiktas AS and Malmo FF at the Besiktas Park on December 13, 2018 in Istanbul, Turkey
    13067130.jpg
  • October 28, 2018 - Doha, Quatar - Victoria Kajoe of  Denmark   during  Uneven Bars qualification at the Aspire Dome in Doha, Qatar, Artistic FIG Gymnastics World Championships on 28 of October 2018. (Credit Image: © Ulrik Pedersen/NurPhoto via ZUMA Press)
    20181028_zaa_n230_174.jpg
  • October 28, 2018 - Doha, Quatar - Emilie Winther of  Denmark   during  Uneven Bars qualification at the Aspire Dome in Doha, Qatar, Artistic FIG Gymnastics World Championships on 28 of October 2018. (Credit Image: © Ulrik Pedersen/NurPhoto via ZUMA Press)
    20181028_zaa_n230_172.jpg
Next